Clinical Trial

Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia

Study acronym: RLRL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the long-term efficacy of repeated low-level red-light (RLRL) therapy in the prevention and control of myopia in children, and to analyze the key factors influencing its efficacy (such as individual differences and compliance), with the aim of providing evidence-based support for the optimization of clinical myopia prevention and control strategies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-30
Trial Details
NCT Number NCT07104513
Lead Sponsor Ruihua Wei
Conditions Myopia
Enrollment 3,000 participants
Start Date 2020-09-28
Primary Completion 2028-07-28 (estimated)
Study Completion 2030-07-28 (estimated)
Updated on ClinicalTrials.gov 2025-09-08